Defining Heart Failure End Points in ST-Segment Elevation Myocardial Infarction Trials-Reference-Cited by-同舟云学术

Defining Heart Failure End Points in ST-Segment Elevation Myocardial Infarction Trials

Published:2012-07 Issue:4 Volume:5 Page:594-600
ISSN:1941-7713
Container-title:Circulation: Cardiovascular Quality and Outcomes
language:en
Short-container-title:Circ: Cardiovascular Quality and Outcomes

Author:

Eapen Zubin J.¹,Tang W.H. Wilson¹,Felker G. Michael¹,Hernandez Adrian F.¹,Mahaffey Kenneth W.¹,Lincoff A. Michael¹,Roe Matthew T.¹

Affiliation:

1. From the Department of Medicine, Duke Clinical Research Institute, Duke University Medical Center, Durham, NC (Z.J.E., G.M.F., A.F.H., K.W.M., M.T.R.); and Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, OH (W.H.W.T., A.M.L.)

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine

Link

https://www.ahajournals.org/doi/pdf/10.1161/CIRCOUTCOMES.112.966150

Reference43 articles.

1. Decline in Rates of Death and Heart Failure in Acute Coronary Syndromes, 1999-2006

2. Trends in reperfusion strategies, door-to-needle and door-to-balloon times, and in-hospital mortality among patients with ST-segment elevation myocardial infarction enrolled in the National Registry of Myocardial Infarction from 1990 to 2006

3. Treatments, Trends, and Outcomes of Acute Myocardial Infarction and Percutaneous Coronary Intervention

4. Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial

5. Ticagrelor Versus Clopidogrel in Patients With ST-Elevation Acute Coronary Syndromes Intended for Reperfusion With Primary Percutaneous Coronary Intervention

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inhibition of tartrate-resistant acid phosphatase 5 can prevent cardiac fibrosis after myocardial infarction;Molecular Medicine;2024-06-15

2. Impact of C-reactive protein levels and role of anakinra in patients with ST-elevation myocardial infarction;International Journal of Cardiology;2024-03

3. Non-coding RNAs and angiogenesis in cardiovascular diseases: a comprehensive review;Molecular and Cellular Biochemistry;2024-02-02

4. Response to interleukin-1 blockade with anakinra in women and men with ST-segment elevation myocardial infarction;Minerva Cardiology and Angiology;2023-11

5. Retinoid X receptor agonists alleviate fibroblast activation and post-infarction cardiac remodeling via inhibition of TGF-β1/Smad pathway;Life Sciences;2023-09